{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-032477","form_type":"8-K","ticker":"PHGE","cik":"0001739174","company_name":"BiomX Inc.","filed_at":"2023-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.327228+00:00","generated_at":"2026-06-16T16:33:22.941312+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.15,"confidence":"high","headline":"BiomX stockholders approve issuance of up to 24.6M shares for purchase agreement","bullets":["Approval of up to 24,632,245 shares of common stock and shares underlying pre-funded warrants per Securities Purchase Agreement dated Feb 22, 2023.","Vote: 13,535,908 for, 691,362 against, 29,429 abstain; no broker non-votes.","Issuance required to comply with NYSE American listing rules.","Shares authorized for potential equity financing to support operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-032477","json":"https://secwatch.observer/filing/0001213900-23-032477.json","markdown":"https://secwatch.observer/filing/0001213900-23-032477.md","text":"https://secwatch.observer/filing/0001213900-23-032477.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739174/000121390023032477/0001213900-23-032477-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739174/000121390023032477/ea177426-8k_biomxinc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T16:33:22.941312+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"594331d36fda4f477cb9a57d3020a77faaf2b951","claim":"BiomX Inc. shareholders approved Approval of the issuance of up to 24,632,245 shares of Common Stock, composed of Shares and Shares underlying pre-funded warrants, in accordance with the Securities Purchase Agreement dated February 22, 2023 at the 2023-04-24 meeting.","evidence_excerpt":"The Company’s stockholders voted to approve the issuance of up to 24,632,245 shares of Common Stock, par value $0.0001 each (“Shares”), composed of Shares and Shares underlying pre-funded warrants, in accordance with the Securities Purchase Agreement dated February 22, 2023, in order to comply with the listing rules of the NYSE American. Voted For Voted Against Abstain Broker Non-Votes 13,535,908 691,362 29,429 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1739174/000121390023032477/0001213900-23-032477-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-04-24"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}